Heartflow, Inc.
HTFL
23 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 10:23 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $29.12 | $657.0K | 519,397(D) | View → |
| May 11, 2026 | May 11 2:20 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $29.12 | $657.0K | — | View → |
| Apr 30, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 948,757 | $29.23 | $27.7M | 8,448,158(I) | View → |
| Apr 29, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 797,133 | $29.37 | $23.4M | 9,396,915(I) | View → |
| Apr 28, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 254,110 | $30.51 | $7.8M | 10,194,048(I) | View → |
| Apr 10, 2026 | Apr 14 9:53 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $26.72 | $602.9K | 549,163(D) | View → |
| Apr 10, 2026 | Apr 10 3:03 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $26.72 | $602.9K | — | View → |
| Apr 1, 2026 | Apr 3 10:15 PM | Campbell RogersChief Medical Officer | Sale | 64,533 | $24.64 | $1.6M | 81,002(D) | View → |
| Apr 1, 2026 | Apr 1 8:23 PM | Rogers Campbell | Proposed Sale | 64,533 | $24.64 | $1.6M | — | View → |
| Mar 19, 2026 | Mar 23 10:33 PM | Campbell RogersChief Medical Officer | Sale | 64,533 | $25.69 | $1.7M | 78,518(D) | View → |
| Mar 18, 2026 | Mar 20 10:24 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 9,725 | $25.00 | $243.1K | 571,725(D) | View → |
| Mar 19, 2026 | Mar 19 8:23 PM | Rogers Campbell | Proposed Sale | 64,533 | $25.69 | $1.7M | — | View → |
| Mar 18, 2026 | Mar 18 6:17 PM | Farquhar John C.M. | Proposed Sale | 9,725 | $25.00 | $243.1K | — | View → |
| Mar 10, 2026 | Mar 12 11:55 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 12,837 | $22.66 | $290.9K | 581,450(D) | View → |
| Mar 10, 2026 | Mar 10 2:53 PM | Farquhar John C.M. | Proposed Sale | 12,837 | $22.66 | $290.9K | — | View → |
| Mar 5, 2026 | Mar 7 1:18 AM | Julie A CullivanDirector | Sale | 9,122 | $25.00 | $228.1K | 27,291(D) | View → |
| Mar 5, 2026 | Mar 5 7:11 PM | Cullivan Julie A | Proposed Sale | 9,122 | $25.00 | $228.1K | — | View → |
| Feb 12, 2026 | Feb 18 1:07 AM | Campbell RogersChief Medical Officer | Sale | 65,153 | $24.49 | $1.6M | 76,034(D) | View → |
| Feb 5, 2026 | Feb 12 10:11 PM | Cullivan Julie A | Proposed Sale | 8,000 | $27.32 | $218.6K | — | View → |
| Feb 12, 2026 | Feb 12 9:45 PM | Rogers Campbell | Proposed Sale | 65,153 | $24.49 | $1.6M | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 3 10:15 PM | Campbell RogersChief Medical Officer | Option Exercise | 67,017 | $8.33 | 81,633(D) | View → |
| Mar 19, 2026 | Mar 23 10:33 PM | Campbell RogersChief Medical Officer | Option Exercise | 67,017 | $2.22 | 141,510(D) | View → |
| Mar 11, 2026 | Mar 12 11:57 PM | Timothy C BarabeDirector | Option Exercise | 8,667 | $2.22 | 15,412(D) | View → |
| Feb 17, 2026 | Feb 20 12:14 AM | Timothy C BarabeDirector | Option Exercise | 2,497 | $8.33 | 0(D) | View → |
| Feb 12, 2026 | Feb 18 1:07 AM | Campbell RogersChief Medical Officer | Option Exercise | 67,016 | $8.33 | 208,527(D) | View → |
| Feb 6, 2026 | Feb 11 1:55 AM | Marie L. JonesChief Accounting Officer, VP | Grant/Award | 37,795 | $27.74 | 37,795(D) | View → |
| Feb 6, 2026 | Feb 11 1:24 AM | John C.M. FarquharDirector, Chief Executive Officer | Grant/Award | 321,259 | $27.74 | 321,259(D) | View → |
| Feb 6, 2026 | Feb 11 1:21 AM | Campbell RogersChief Medical Officer | Grant/Award | 94,488 | $27.74 | 94,488(D) | View → |
| Feb 6, 2026 | Feb 11 1:18 AM | Vikram VergheseChief Financial Officer | Grant/Award | 119,685 | $27.74 | 119,685(D) | View → |